123 related articles for article (PubMed ID: 18421017)
1. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types.
Queisser MA; Kouri FM; Königshoff M; Wygrecka M; Schubert U; Eickelberg O; Preissner KT
Am J Respir Cell Mol Biol; 2008 Sep; 39(3):337-45. PubMed ID: 18421017
[TBL] [Abstract][Full Text] [Related]
2. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
3. The role of the receptor for advanced glycation end-products in lung fibrosis.
He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
[TBL] [Abstract][Full Text] [Related]
4. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
Andreutti D; Gabbiani G; Neuville P
Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
[TBL] [Abstract][Full Text] [Related]
5. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis.
Takahashi F; Takahashi K; Okazaki T; Maeda K; Ienaga H; Maeda M; Kon S; Uede T; Fukuchi Y
Am J Respir Cell Mol Biol; 2001 Mar; 24(3):264-71. PubMed ID: 11245625
[TBL] [Abstract][Full Text] [Related]
6. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis.
Königshoff M; Wilhelm A; Jahn A; Sedding D; Amarie OV; Eul B; Seeger W; Fink L; Günther A; Eickelberg O; Rose F
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):640-50. PubMed ID: 17630322
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis.
Englert JM; Kliment CR; Ramsgaard L; Milutinovic PS; Crum L; Tobolewski JM; Oury TD
Int J Clin Exp Pathol; 2011 Mar; 4(3):241-54. PubMed ID: 21487520
[TBL] [Abstract][Full Text] [Related]
8. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
9. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.
Miyazaki Y; Araki K; Vesin C; Garcia I; Kapanci Y; Whitsett JA; Piguet PF; Vassalli P
J Clin Invest; 1995 Jul; 96(1):250-9. PubMed ID: 7542280
[TBL] [Abstract][Full Text] [Related]
10. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of aquaporin-5 in bleomycin-induced lung fibrosis in the mouse.
Gabazza EC; Kasper M; Ohta K; Keane M; D'Alessandro-Gabazza C; Fujimoto H; Nishii Y; Nakahara H; Takagi T; Menon AG; Adachi Y; Suzuki K; Taguchi O
Pathol Int; 2004 Oct; 54(10):774-80. PubMed ID: 15482567
[TBL] [Abstract][Full Text] [Related]
12. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation.
Reynolds PR; Kasteler SD; Schmitt RE; Hoidal JR
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):411-8. PubMed ID: 21131443
[TBL] [Abstract][Full Text] [Related]
14. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
16. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
[TBL] [Abstract][Full Text] [Related]
18. Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis.
Kass D; Bridges RS; Borczuk A; Greenberg S
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):193-201. PubMed ID: 17446530
[TBL] [Abstract][Full Text] [Related]
19. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis.
Baecher-Allan CM; Barth RK
Reg Immunol; 1993; 5(3-4):207-17. PubMed ID: 7694632
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
